MIT and DIT Blood Measurement for Thyroiditis Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating destructive thyroiditis from other thyroid conditions, such as Graves' disease, lack accuracy and convenience, particularly in determining thyroid hormone levels and antibody measurements.
Innovation Solution
Measuring monoiodotyrosine (MIT) and diiodotyrosine (DIT) levels in blood samples using liquid chromatography-tandem mass spectrometry (LC-MS/MS) to differentiate destructive thyroiditis from non-destructive thyroiditis diseases, with cutoff values for precise differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If anti-TSH receptor antibody (TRAb) measurement is performed to differentiate destructive thyroiditis from Graves' disease, then diagnostic information can be obtained, but the measurement lacks precision because TRAb is not a single antibody and can be positive in other conditions like idiopathic myxoedema, subacute thyroiditis, and painless thyroiditis
Solution Approach 1:
The invention extracts and measures specific thyroid hormone levels (FT3, FT4, and the ratio FT3/FT4) separately from the problematic TRAb measurement. By focusing on these extracted parameters with established reference values, the method avoids the precision issues of TRAb while maintaining diagnostic information completeness for differentiating destructive thyroiditis from Graves' disease
Solution Approach 2:
The invention changes the measurement parameters from TRAb (which lacks precision) to thyroid hormone levels FT3, FT4, and their ratio. These parameter changes enable precise differentiation: destructive thyroiditis shows high FT3/FT4 ratio with normal or low TSH, while Graves' disease shows different patterns, providing accurate diagnostic criteria without the ambiguity of TRAb positivity
2Ease of operation
If FT3/FT4 ratio measurement is used to differentiate destructive thyroiditis from Graves' disease, then a simple measurement approach is provided, but the sensitivity and specificity are low making accurate differentiation difficult
Solution Approach 1:
The invention merges multiple measurement parameters (FT3 level, FT4 level, and their ratio FT3/FT4) into a comprehensive diagnostic approach. By combining these measurements with TSH levels and comparing against established reference values, the method maintains ease of operation while significantly improving differentiation accuracy and reliability compared to using the FT3/FT4 ratio alone
3Loss of information
If blood flow index or blood flow density measurement is performed to differentiate destructive thyroiditis from Graves' disease, then additional diagnostic information can be obtained, but the values may overlap with Graves' disease making clear differentiation difficult
Solution Approach 1:
The invention extracts and measures serum iodine levels as a separate, independent parameter that is not affected by blood flow variations. By measuring iodine concentration directly in serum and comparing against reference values, the method obtains clear diagnostic information without the overlapping values and discrimination problems associated with blood flow index or blood flow density measurements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Accurately distinguishes destructive thyroiditis from conditions like Graves' disease, providing a reliable diagnostic tool with high sensitivity and specificity.
Implementation Method 1
Measuring monoiodotyrosine (MIT) and diiodotyrosine (DIT) levels in blood samples using liquid chromatography-tandem mass spectrometry (LC-MS/MS)
Implementation Method 2
Measuring monoiodotyrosine (MIT) and diiodotyrosine (DIT) levels in blood samples using liquid chromatography-tandem mass spectrometry (LC-MS/MS)
Data Source
AI summary
Described is a method for differentiating destructive thyroiditis, including measuring at least one of monoiodotyrosine and diiodotyrosine in a sample.